Enzalutamide is an oral medication targeting advanced prostate cancer. The drug inhibits androgen receptor activity, blocking the effects of testosterone on the cancerous cells, hence slowing down the tumour growth in patients, enabling them to have a better quality of life. https://thesmscity.com/blogs/understanding-the-economics-of-enzalutamide-in-the-usa/